Abstract
Brachytherapy is an important radio-therapeutic modality for a variety of malignancies, including prostate cancer, cervix cancer, breast cancer, vagina cancer, endometrium cancer, head and neck cancer, and many more. This technique has been shown to be an effective and safe non-pharmaceutical treatment with fewer serious complications and better outcome than other treatments for breast cancer. Every year, hundreds of thousands of patients around the world benefit from brachytherapy, which reliably delivers a relatively higher radiation dose to the intended target. However, the follow-up time, patient eligibility criteria, treatment strategy, and radiation doses used in published studies are somewhat inconsistent, making it difficult to strictly compare and evaluate the performance of the treatment. More rigorous studies are required to confirm the safety of this technique and to make outcome data more comparable. In this review, we focus on recent advances in breast brachytherapy techniques and provide an overview of outcomes, cosmetic outcome, toxicity, complications, and limitations of brachytherapy for the treatment of breast cancer. We also summarize the clinical outcomes and toxicity results in patients receiving or not receiving brachytherapy.
Similar content being viewed by others
References
Ferlay J, Soerjomataram I, Dikshit R et al (2012) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN. Int J Cancer 136:E359–386
Jia M, Zheng R, Zhang S et al (2015) Female breast cancer incidence and mortality in 2011, China. J Thorac Dis 7:1221–1226
Beitsch PD, Hodge CW, Dowlat K et al (2009) The surgeon’s role in breast brachytherapy. Breast J 15:93–100
Sarin R (2005) Partial-breast treatment for early breast cancer: emergence of a new paradigm. Nat Clin Pract Oncol 2:40–47
Sauer G, Strnad V, Kurzeder C et al (2005) Partial breast irradiation after breast-conserving surgery. Strahlenther Onkol 181:1–8
Mille MM, Xu XG, Rivard MJ (2010) Comparison of organ doses for patients undergoing balloon brachytherapy of the breast with HDR 192Ir or electronic sources using monte carlo simulations in a heterogeneous human phantom. Med Phys 37:662–671
Fentiman IS, Poole C, Tong D et al (1991) Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot study. Eur J Cancer 27:447–450
Fentiman IS, Poole C, Tong D et al (1996) Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer 32A:608–611
Vicini FA, Kestin LL, Edmundson GK et al (1999) Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys 45:803–810
Kestin LL, Jaffray DA, Edmundson GK et al (2000) Improving the dosimetric coverage of interstitial high-dose-rate breast implants. Int J Radiat Oncol Biol Phys 46:35–43
Das RK, Patel R, Shah H et al (2004) 3D CT-based high-dose-rate breast brachytherapy implants: treatment planning and quality assurance. Int J Radiat Oncol Biol Phys 59:1224–1228
Major T, Fodor J, Takacsi-Nagy Z et al (2005) Evaluation of HDR interstitial breast implants planned by conventional and optimized CT-based dosimetry systems with respect to dose homogeneity and conformality. Strahlenther Onkol 181:89–96
Gloi A, McCourt S, Buchanan R et al (2009) Dosimetric parameters in partial breast irradiation through brachytherapy. Med Dosim 34:207–213
Budrukkar A, Gurram L, Upreti RR et al (2015) Clinical outcomes of prospectively treated 140 women with early stage breast cancer using accelerated partial breast irradiation with 3 dimensional computerized tomography based brachytherapy. Radiother Oncol 115:349–354
Jolicoeur M, Racine ML, Trop I et al (2011) Localization of the surgical bed using supine magnetic resonance and computed tomography scan fusion for planification of breast interstitial brachytherapy. Radiother Oncol 100:480–484
Mast M, Coerkamp E, Heijenbrok M et al (2014) Target volume delineation in breast conserving radiotherapy: are co-registered CT and MR images of added value? Radiat Oncol 9:65
Poulin E, Gardi L, Barker K et al (2015) Validation of a novel robot-assisted 3DUS system for real-time planning and guidance of breast interstitial HDR brachytherapy. Med Phys 42:6830–6839
Wazer DE, Berle L, Graham R et al (2002) Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys 53:889–897
Ott OJ, Potter R, Hammer J et al (2004) Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy. Preliminary results of the German–Austrian multicenter trial. Strahlenther Onkol 180:642–649
Benitez PR, Chen PY, Vicini FA et al (2004) Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy. Am J Surg 188:355–364
Strnad V, Ott O, Potter R et al (2004) Interstitial brachytherapy alone after breast conserving surgery: interim results of a German-Austrian multicenter phase II trial. Brachytherapy 3:115–119
Hannoun-Levi JM, Houvenaeghel G, Ellis S et al (2004) Partial breast irradiation as second conservative treatment for local breast cancer recurrence. Int J Radiat Oncol Biol Phys 60:1385–1392
Wazer DE, Kaufman S, Cuttino L et al (2006) Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys 64:489–495
Nose T, Komoike Y, Yoshida K et al (2006) A pilot study of wider use of accelerated partial breast irradiation: intraoperative margin-directed re-excision combined with sole high-dose-rate interstitial brachytherapy. Breast Cancer 13:289–299
Chen PY, Vicini FA, Benitez P et al (2006) Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer 106:991–999
Yoshida K, Nose T, Masuda N et al (2009) Preliminary result of accelerated partial breast irradiation after breast-conserving surgery. Breast Cancer 16:105–112
Johansson B, Karlsson L, Liljegren G et al (2009) Pulsed dose rate brachytherapy as the sole adjuvant radiotherapy after breast-conserving surgery of T1-T2 breast cancer: first long time results from a clinical study. Radiother Oncol 90:30–35
Polgar C, Major T, Fodor J et al (2010) Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study. Radiother Oncol 94:274–279
Yeo SG, Kim J, Kwak GH et al (2010) Accelerated partial breast irradiation using multicatheter brachytherapy for select early-stage breast cancer: local control and toxicity. Radiat Oncol 5:56
Strnad V, Hildebrandt G, Potter R et al (2011) Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery. Int J Radiat Oncol Biol Phys 80:17–24
Kauer-Dorner D, Potter R, Resch A et al (2012) Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial. Radiother Oncol 102:96–101
Shah C, McGee M, Wilkinson JB et al (2012) Clinical outcomes using accelerated partial breast irradiation in patients with ductal carcinoma in situ. Clin Breast Cancer 12:259–263
Hannoun-Levi JM, Resch A, Gal J et al (2013) Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group. Radiother Oncol 108:226–231
Kamrava M, Kuske RR, Anderson B et al (2015) Outcomes of breast cancer patients treated with accelerated partial breast irradiation via multicatheter interstitial brachytherapy: the Pooled Registry of Multicatheter Interstitial Sites (PROMIS) Experience. Ann Surg Oncol 22[Suppl 3]:404–411
Lovey K, Fodor J, Major T et al (2007) Fat necrosis after partial-breast irradiation with brachytherapy or electron irradiation versus standard whole-breast radiotherapy–4-year results of a randomized trial. Int J Radiat Oncol Biol Phys 69:724–731
Antonucci JV, Wallace M, Goldstein NS et al (2009) Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up. Int J Radiat Oncol Biol Phys 74:447–452
Wadasadawala T, Sarin R, Budrukkar A et al (2009) Accelerated partial-breast irradiation vs conventional whole-breast radiotherapy in early breast cancer: a case-control study of disease control, cosmesis, and complications. J Cancer Res Ther 5:93–101
Shah C, Antonucci JV, Wilkinson JB et al (2011) Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: results of a matched-pair analysis. Radiother Oncol 100:210–214
Ferraro DJ, Garsa AA, DeWees TA et al (2012) Comparison of accelerated partial breast irradiation via multicatheter interstitial brachytherapy versus whole breast radiation. Radiat Oncol 7:53
Strnad V, Ott OJ, Hildebrandt G et al (2016) 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet 387:229–238
Perrucci E, Lancellotta V, Bini V et al (2015) Quality of life and cosmesis after breast cancer: whole breast radiotherapy vs partial breast high-dose-rate brachytherapy. Tumori 101:161–167
Bodacs I, Polgar C, Major T (2014) Dosimetric comparison of external partial breast irradiation with whole breast irradiation and partial breast brachytherapy. Magy Onkol 58:108–115
Chan TY, Tan PW, Tan CW et al (2015) Assessing radiation exposure of the left anterior descending artery, heart and lung in patients with left breast cancer: a dosimetric comparison between multicatheter accelerated partial breast irradiation and whole breast external beam radiotherapy. Radiother Oncol 117:459–466
Anbumani S, Palled SR, Prabhakar GS et al (2012) Accelerated partial breast irradiation using external beam radiotherapy-A feasibility study based on dosimetric analysis. Rep Pract Oncol Radiother 17:200–206
Roy S, Devleena Maji T et al (2013) Tumor bed boost in breast cancer: brachytherapy versus electron beam. Indian J Med Paediatr Oncol 34:257–263
Shah C, Khwaja S, Badiyan S et al (2013) Brachytherapy-based partial breast irradiation is associated with low rates of complications and excellent cosmesis. Brachytherapy 12:278–284
Patel PS, Yan W, Trichter S et al (2011) Seroma is an expected consequence and not a complication of MammoSite brachytherapy. Breast J 17:498–502
Ravi A, Lee S, Karsif K et al (2010) Intraoperative placement of MammoSite for breast brachytherapy treatment and seroma incidence. Brachytherapy 9:76–80
Shaitelman SF, Vicini FA, Beitsch P et al (2010) Five-year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breast Surgeons MammoSite Registry Trial. Cancer 116:4677–4685
Beitsch P, Vicini F, Keisch M et al (2010) Five-year outcome of patients classified in the “unsuitable” category using the American Society of Therapeutic Radiology and Oncology (ASTRO) Consensus Panel guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breast Surgeons MammoSite(R) Registry trial. Ann Surg Oncol 17[Suppl 3]:219–225
Aburabia M, Roses RE, Kuerer HM et al (2011) Axillary failure in patients treated with MammoSite accelerated partial breast irradiation. Ann Surg Oncol 18:3415–3421
Shah C, Vicini F, Keisch M et al (2012) Outcome after ipsilateral breast tumor recurrence in patients who receive accelerated partial breast irradiation. Cancer 118:4126–4131
Khan AJ, Vicini FA, Beitsch P et al (2012) Local control, toxicity, and cosmesis in women > 70 years enrolled in the American Society of Breast Surgeons accelerated partial breast irradiation registry trial. Int J Radiat Oncol Biol Phys 84:323–330
Shah C, Badiyan S, Ben Wilkinson J et al (2013) Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite((R)) breast brachytherapy registry trial. Ann Surg Oncol 20:3279–3285
Zauls AJ, Watkins JM, Wahlquist AE et al (2012) Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO Accelerated Partial Breast Irradiation Consensus Statement Groups. Int J Radiat Oncol Biol Phys 82:21–29
Beitsch PD, Wilkinson JB, Vicini FA et al (2012) Tumor bed control with balloon-based accelerated partial breast irradiation: incidence of true recurrences versus elsewhere failures in the American Society of Breast Surgery MammoSite((R)) Registry Trial. Ann Surg Oncol 19:3165–3170
Shah C, Wilkinson JB, Lyden M et al (2012) Comparison of survival and regional failure between accelerated partial breast irradiation and whole breast irradiation. Brachytherapy 11:311–315
Sher DJ, Wittenberg E, Suh WW et al (2009) Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis. Int J Radiat Oncol Biol Phys 74:440–446
Rivera R, Banks A, Casillas-Lopez A et al (2016) Targeted intraoperative radiotherapy for the management of ductal carcinoma in situ of the breast. Breast J 22:63–74
Trifiletti DM, Romano KD, Showalter SL et al (2015) Accelerated partial breast irradiation with brachytherapy: patient selection and technique considerations. Breast Cancer 7:211–221
Shah C, Wilkinson JB, Lyden M et al (2012) Predictors of local recurrence following accelerated partial breast irradiation: a pooled analysis. Int J Radiat Oncol Biol Phys 82:e825–830
Wilder RB, Curcio LD, Khanijou RK et al (2010) Results with accelerated partial breast irradiation in terms of estrogen receptor, progesterone receptor, and human growth factor receptor 2 status. Int J Radiat Oncol Biol Phys 78:799–803
Khan AJ, Vicini F, Beitsch P et al (2009) Local control, toxicity, and cosmesis in women younger than 50 enrolled onto the American Society of Breast Surgeons MammoSite Radiation Therapy System registry trial. Ann Surg Oncol 16:1612–1618
Kaufman SA, Dipetrillo TA, Ruthazer R et al (2005) MammoSite excision volume as a predictor for residual disease. Cancer 104:906–912
Dragun AE, Harper JL, Jenrette JM et al (2007) Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys 68:354–358
Goyal S, Khan AJ, Vicini F et al (2009) Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial breast irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Breast Brachytherapy Registry Trial. Ann Surg Oncol 16:2450–2458
Watkins JM, Harper JL, Dragun AE et al (2008) Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy. Brachytherapy 7:305–309
Vicini FA, Keisch M, Shah C et al (2012) Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy. Int J Radiat Oncol Biol Phys 83:512–518
Shah C, Wilkinson JB, Keisch M et al (2013) Impact of margin status on outcomes following accelerated partial breast irradiation using single-lumen balloon-based brachytherapy. Brachytherapy 12:91–98
Vicini FA, Beitsch PD, Quiet CA et al (2005) First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Cancer 104:1138–1148
Haffty BG, Vicini FA, Beitsch P et al (2008) Timing of chemotherapy after MammoSite radiation therapy system breast brachytherapy: analysis of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Int J Radiat Oncol Biol Phys 72:1441–1448
Hepel JT, Hiatt JR, Cardarelli GA et al (2010) Modeling study for optimization of skin dose for partial breast irradiation using Xoft Axxent electronic brachytherapy applicator. Brachytherapy 9:81–85
Dickler A, Kirk MC, Seif N et al (2007) A dosimetric comparison of MammoSite high-dose-rate brachytherapy and Xoft Axxent electronic brachytherapy. Brachytherapy 6:164–168
Cifter G, Chin J, Cifter F et al (2015) Targeted radiotherapy enhancement during electronic brachytherapy of accelerated partial breast irradiation (APBI) using controlled release of gold nanoparticles. Phys Med 31:1070–1074
Chen SS, Strauss JB, Shah AP et al (2009) Radiation recall reaction with docetaxel administration after accelerated partial breast irradiation with electronic brachytherapy. Brachytherapy 8:331–334
Funding
This study was supported by the Program of Hebei Administration of Traditional Chinese Medicine (2013031).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflicts of interest.
About this article
Cite this article
Deng, X., Wu, H., Gao, F. et al. Brachytherapy in the treatment of breast cancer. Int J Clin Oncol 22, 641–650 (2017). https://doi.org/10.1007/s10147-017-1155-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-017-1155-5